蛋白质稳态
线粒体生物发生
生物
线粒体
生物能学
线粒体DNA
细胞生物学
氧化应激
粒体自噬
生物发生
心肌病
遗传学
自噬
生物化学
基因
内科学
医学
细胞凋亡
心力衰竭
作者
Nicole M. Sayles,Nneka Southwell,Kevin McAvoy,Kihwan Kim,Alba Pesini,Corey J. Anderson,Catarina Maria Quinzii,Suzanne M. Cloonan,Hibiki Kawamata,Giovanni Manfredi
出处
期刊:Cell Reports
[Cell Press]
日期:2022-03-01
卷期号:38 (10): 110475-110475
被引量:33
标识
DOI:10.1016/j.celrep.2022.110475
摘要
Mitochondrial cardiomyopathies are fatal diseases, with no effective treatment. Alterations of heart mitochondrial function activate the mitochondrial integrated stress response (ISR mt ), a transcriptional program affecting cell metabolism, mitochondrial biogenesis, and proteostasis. In humans, mutations in CHCHD10, a mitochondrial protein with unknown function, were recently associated with dominant multi-system mitochondrial diseases, whose pathogenic mechanisms remain to be elucidated. Here, in CHCHD10 knockin mutant mice, we identify an extensive cardiac metabolic rewiring triggered by proteotoxic ISR mt . The stress response arises early on, before the onset of bioenergetic impairments, triggering a switch from oxidative to glycolytic metabolism, enhancement of transsulfuration and one carbon (1C) metabolism, and widespread metabolic imbalance. In parallel, increased NADPH oxidases elicit antioxidant responses, leading to heme depletion. As the disease progresses, the adaptive metabolic stress response fails, resulting in fatal cardiomyopathy. Our findings suggest that early interventions to counteract metabolic imbalance could ameliorate mitochondrial cardiomyopathy associated with proteotoxic ISR mt .
科研通智能强力驱动
Strongly Powered by AbleSci AI